Scopus BioPharma Inc. (SCPS)

AI Score

Unlock

0.00

-0.00 (-100.00%)

At close: Mar 24, 2025, 11:51 AM

Scopus BioPharma Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q3 2019	Q2 2019	Q1 2019	Q2 2018	Q1 2018
Period Ending	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019	Jun 30, 2018	Mar 31, 2018
Net Income	-2.93M	-2.68M	-1.84M	-1.9M	-3.32M	-4.66M	-6.52M	-1.4M	-15.63M	-3.41M	-1.05M	-1.16M	-8.03M	-626.14K	-963.89K	-797.22K	-437.19K	-491.65K	-152.23K	-122.49K
Depreciation & Amortization	334.00	231.00	231.00	306.00	582.00	609.00	353.00	375.00	400.00	372.00	367.00	362.00	355.00	356.00	580.00	46.00	n/a	n/a	n/a	n/a
Stock-Based Compensation	78.11K	78.11K	78.11K	83.56K	95.03K	95.03K	144.23K	154.47K	187.57K	183.33K	69.64K	80.25K	60.26K	60.26K	-28.88K	73.52K	39.93K	39.93K	n/a	n/a
Other Working Capital	1.84M	1.84M	-3B	n/a	111.5K	-976.1M	-2.94B	n/a	n/a	-229.66K	-1.4M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Non-Cash Items	n/a	n/a	3.23B	n/a	n/a	n/a	143.53K	86.59K	12.98M	259.76K	279.76K	225.32K	6.41M	5.36K	89.15K	n/a	38.00	n/a	n/a	n/a
Deferred Income Tax	n/a	n/a	-3.23B	n/a	n/a	n/a	n/a	-1.47M	14.27K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	1.84M	1.84M	1.34M	963.09K	348.44K	587.62K	2.08M	112.31K	481.8K	165.03K	-218.15K	192.98K	740.63K	433.42K	297.32K	121.97K	-227.48K	163.43K	40.48K	-88.42K
Operating Cash Flow	-1.01M	-759.86K	-421.9K	-851.65K	-2.88M	-3.98M	-4.15M	-2.52M	-1.96M	-2.8M	-919.29K	-661.07K	-818.18K	-126.75K	-605.72K	-601.68K	-624.71K	-288.3K	-111.75K	-210.91K
Capital Expenditures	n/a	n/a	-1.55M	n/a	n/a	-1.55K	-2M	-2K	n/a	n/a	n/a	n/a	n/a	n/a	-689	-1.31K	n/a	n/a	n/a	n/a
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	n/a	n/a	-1.55M	n/a	n/a	-1.55K	-2M	-2K	n/a	n/a	n/a	n/a	n/a	n/a	-689	-1.31K	-2.25K	n/a	n/a	n/a
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-104.5K	n/a	n/a	729.7K	228K	1.1M	130K	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	n/a	n/a	241.94K	n/a	n/a	n/a	-1.27M	n/a	-19.13K	-1.15M	-801.39K	-119.73K	-138.1K	-51.18K	-252.98K	-58.27K	955.19K	-236.72K	-520	44.73K
Financial Cash Flow	-44.69K	2.02M	241.94K	n/a	n/a	n/a	8.48M	-104.5K	-19.13K	9.2M	2.36M	331.81K	1.58M	80.82K	-2.98K	392.23K	959.5K	834.96K	-520	183.21K
Net Cash Flow	-1.04M	1.28M	-186.25K	-845.64K	-2.82M	-3.97M	4.31M	-2.63M	-1.99M	6.42M	1.41M	-332.69K	748.45K	-31.95K	-633.66K	-199.01K	322.94K	544.82K	-112.27K	-27.7K
Free Cash Flow	-1.01M	-759.86K	-1.97M	-851.65K	-2.88M	-3.98M	-6.15M	-2.52M	-1.96M	-2.8M	-919.29K	-661.07K	-818.18K	-126.75K	-606.41K	-602.99K	-624.71K	-288.3K	-111.75K	-210.91K